BLISS GVS PHARMA
Back to Cashflow Statement
|
BLISS GVS PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹106 Cr | ₹103 Cr | ₹34 Cr | ₹135 Cr | ₹64 Cr |
What is the latest Cash Flow from Operating Activities ratio of BLISS GVS PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹106 Cr |
| Mar2024 | ₹103 Cr |
| Mar2023 | ₹34 Cr |
| Mar2022 | ₹135 Cr |
| Mar2021 | ₹64 Cr |
How is Cash Flow from Operating Activities of BLISS GVS PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹106 Cr | 3.01 | |
| Mar2024 | ₹103 Cr | 199.64 | |
| Mar2023 | ₹34 Cr | -74.67 | |
| Mar2022 | ₹135 Cr | 111.79 | |
| Mar2021 | ₹64 Cr | - | |
Compare Cash Flow from Operating Activities of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹2,163.6 Cr | -4.4% | 10.2% | 75.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,704.0 Cr | 3.1% | 6.2% | 13.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,223.0 Cr | -1% | 3.3% | 14.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,928.0 Cr | -0% | 10% | 45.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,368.0 Cr | -0.6% | 3.3% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | -2% | -0.6% | -6.1% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | -4.4% |
10.2% |
75.7% |
| SENSEX | -4.6% |
-7.5% |
6% |
You may also like the below Video Courses